StonvexLoading…
StonvexStonvexStonvexCore line items from CNTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $35.84M | $26.21M | $17.50M | $8.99M |
Operating Income | $-12.59M | $-9.41M | $-6.59M | $-3.27M |
Net Income | $-16.25M | $-11.71M | $-10.56M | $-7.02M |
EPS (Diluted) | $-0.22 | $-0.22 | $-0.24 | $-0.22 |
Total Assets | $36.17M | $22.09M | $21.84M | $12.75M |
Total Liabilities | $34.59M | $33.84M | $33.42M | $38.72M |
Cash & Equivalents | $2.90M | $2.21M | $2.66M | $1.62M |
Free Cash Flow OCF − CapEx | Not available | $-6.70M | $-4.21M | $-2.83M |
Shares Outstanding | 153.26M | 94.61M | 71.63M | 35.51M |